| Oropharyngeal Neoplasm studied in …STUDIED_INderived10 of 487show all (up to 200) |
|---|
| → studied in | NCT06309225NA · recruiting Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly · condition mapped ALIAS · 487 trials mapped (186 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 487 trials mapped (186 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 487 trials mapped (186 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03644563active not recruiting Men and Women Offering Understanding of Throat HPV · condition mapped CURATED_EXACT · 487 trials mapped (186 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 487 trials mapped (186 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 487 trials mapped (186 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05814549active not recruiting A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) · condition mapped CURATED_EXACT · 487 trials mapped (186 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305676recruiting Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) · condition mapped CURATED_EXACT · 487 trials mapped (186 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266093enrolling by invitation Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies · condition mapped ONTOLOGY_EXACT · 487 trials mapped (186 active) | — | — | Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 487 trials mapped (186 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |